Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 6/20 | 0.44 |
| ▸ | ADH1C | P00326 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.40 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.40 |
| ▸ | EBP | Q15125 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30750 | 0.87 | ALDH1A1 (0.41) | ADH1AADH1CALDH1A1SIGMAR1KDM4E | |
| Ammonia Solution, Strong SCHEMBL17439397 | 0.85 | ALDH1A1 (0.40) | ADH1AADH1CALDH1A1SIGMAR1KDM4E | |
| Hydrochloric Acid SCHEMBL2957420 | 0.85 | ALDH1A1 (0.40) | ADH1AADH1CALDH1A1SIGMAR1KDM4E | |
| Fluoride SCHEMBL9620616 | 0.85 | ALDH1A1 (0.40) | ADH1AADH1CALDH1A1SIGMAR1KDM4E | |
| SCHEMBL2163192 | 0.84 | ALDH1A1 (0.38) | ADH1AADH1CALDH1A1SIGMAR1 | |
| SCHEMBL3429552 | 0.84 | ADH1A (0.47) | ADH1AADH1CALDH1A1LMNA | |
| SCHEMBL10582372 | 0.83 | ALDH1A1 (0.39) | ADH1AADH1CALDH1A1 | |
| SCHEMBL29957210 | 0.81 | ADH1A (0.55) | ADH1AADH1CALDH1A1SIGMAR1TMEM97 | |
| SCHEMBL737248 | 0.80 | ADH1A (0.43) | ADH1AADH1CALDH1A1SIGMAR1TMEM97 | |
| SCHEMBL12473169 | 0.80 | SHBG (0.32) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2827415-A1 | POLYMER ELECTROLYTE MEMBRANE HAVING GRAFT CHAIN, AND PRODUCTION METHOD THEREFOR | Nitto Denko Corporation (JP) | 2015-01-21 | — | — | EP | claimed |
| US-20150010848-A1 | POLYMER ELECTROLYTE MEMBRANE HAVING GRAFT CHAINS, AND METHOD FOR PRODUCING THE SAME | NITTO DENKO CORPORATION (JP) | 2015-01-08 | — | — | US | claimed |
| CN-104170137-A | Polymer electrolyte membrane having graft chain, and production method therefor | NITTO DENKO CORP | 2014-11-26 | — | — | CN | claimed |
| US-20200332131-A1 | FLAME RETARDANT AID, FLAME RETARDING AGENT COMPOSITION, AND METHOD FOR PRODUCING FLAME-RETARDANT FIBER FABRIC | NICCA CHEMICAL CO., LTD. (JP) | 2020-10-22 | — | — | US | disclosed |
| EP-2827415-A1 | POLYMER ELECTROLYTE MEMBRANE HAVING GRAFT CHAIN, AND PRODUCTION METHOD THEREFOR | Nitto Denko Corporation (JP) | 2015-01-21 | — | — | EP | disclosed |
| US-20150010848-A1 | POLYMER ELECTROLYTE MEMBRANE HAVING GRAFT CHAINS, AND METHOD FOR PRODUCING THE SAME | NITTO DENKO CORPORATION (JP) | 2015-01-08 | — | — | US | disclosed |
| CN-104170137-A | Polymer electrolyte membrane having graft chain, and production method therefor | NITTO DENKO CORP | 2014-11-26 | — | — | CN | disclosed |
| EP-2199265-B1 | GLASS FIBER SIZING AGENT CONTAINING AMPHOTERIC POLYMER COMPOUND | NITTO BOSEKI CO LTD (JP) | 2012-11-07 | — | — | EP | disclosed |
| CN-101687698-B | Glass fiber sizing agent containing amphoteric polymer compound | NITTO BOSEKI CO LTD | 2012-08-01 | — | — | CN | disclosed |
| US-20100215940-A1 | Glass Fiber Sizing Agent Containing Amphoteric Polymer Compound | NITTO BOSEKI CO., LTD. (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-2199265-A1 | GLASS FIBER SIZING AGENT CONTAINING AMPHOTERIC POLYMER COMPOUND | Nitto Boseki CO., LTD. (JP) | 2010-06-23 | — | — | EP | disclosed |
| CN-101687698-A | Glass fiber sizing agent containing amphoteric polymer compound | NITTO BOSEKI CO LTD | 2010-03-31 | — | — | CN | disclosed |
| US-7326703-B2 | (1,10B-Dihydro-2-(aminocarbonyl-phenyl)-5H-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors | TIBOTEC PHARMACEUTICALS LTD (IL) | 2008-02-05 | — | — | US | disclosed |
| US-20070248624-A1 | (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors | JANSSEN SCIENCES IRELAND UC (IE) | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070248624-A1 | (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors | POLRMT, MAVS, DHX15 | ADH1A 919/4885ADH1C 401/4885ALDH1A1 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.